Online Program

331255
Leading through Health System Change: The development of an MCH health reform planning tool


Wednesday, November 4, 2015 : 8:40 a.m. - 8:50 a.m.

Glenn Landers, Sc.D., MBA, MHA, Georgia Health Policy Center, Georgia State University, Atlanta, GA
Karen Minyard, Ph.D., M.S.N., Georgia Health Policy Center, Georgia State University, Atlanta, GA
Liz Imperiale, BSBA, Georgia Health Policy Center, Georgia State University, Atlanta, GA
Mary Ann Phillips, MPH, Georgia Health Policy Center, Georgia State University, Atlanta, GA
Christopher A. Parker, MBBS, MPH, Georgia Health Policy Center, Georgia State University, Atlanta, GA
Amy Mullenix, MSPH, MSW, The National MCH Workforce Development Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC
Dorothy Cilenti, DrPH, MPH, MSW, The National MCH Workforce Development Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC
Melissa Haberlen, JD, MPH, Georgia Health Policy Center, Georgia State University, Atlanta, GA
Brittney Romanson, MPH, CHES, Georgia Health Policy Center, Georgia State University, Atlanta, GA
Background: The Affordable Care Act (ACA) provides many opportunities for improving maternal and child health services and outcomes. A Maternal and Child Health (MCH) module was developed in partnership with the National MCH Workforce Development Center and added to the existing decision-support tool “Leading through Health System Change: A Public Health Opportunity” to leverage these opportunities to advance quality maternal and child health programs. Users have the opportunity to apply adaptive thinking, while being guided through case examples, and plan strategically in the face of health transformation.

Methods: The MCH module was designed by ACA and MCH experts using environmental scanning and formative research to characterize the expected impacts of the ACA on maternal and child health populations and services.

Results: Formative research led to the use of the MCH pyramid as a guiding framework for the module, which provides four alternate pathways for program planning. The tool was reviewed with 27 state MCH program leaders at a workshop following a national MCH meeting in early 2015. Twenty-five participants provided feedback on the pathways described, with 57% selecting “to take/assume a leadership role in building and developing supportive infrastructure for systems serving mothers and children” as their desired program planning pathway.

Conclusions: State MCH programs have vital questions related to how health transformation affects their role in the provision of MCH services. This tool provides a new conceptual framework that will lead to strategic action and innovation for MCH program leaders and their partners participating in health transformation efforts.

Learning Areas:

Implementation of health education strategies, interventions and programs
Provision of health care to the public
Public health or related laws, regulations, standards, or guidelines

Learning Objectives:
Describe the key areas of Maternal and Child Health provisions of the Affordable Care Act, including insurance access, coverage of prevention health services, and care coordination and community benefit. Discuss the five-step planning process and differences between technical and adaptive challenges. Learning to use the five-step planning process and an adaptive-problem solving approach are, we believe, the key to responding to this opportunity of change. Explain the simplified implementation plan and understand how to use the interactive planning tool to answer questions related to Maternal and Child Health in the face of health transformation.

Keyword(s): Maternal and Child Health, Health Systems Transformation

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I am one of the authors and creators of the Leading through health System Change Planning Tool.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.

Back to: 5061.0: Impact of ACA on MCH